
| 2020 | |
|---|---|
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | > 1000 |
| Total Number of Projects: | > 1000 |
| 2011 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2020 | 0 | 9.997.870 | 300.000 | 1 | ||
| 2017 | 0 | 16.150.271 | 795.903 | 2 | ||
| 2011 | 0 | 5.841.009 | 688.500 | 1 | ||
Total number of partners: 78
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 78
Frequent / Rare Partner Ratio: 0
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2020-10-01 | An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum | ProCAncer-I | participant | 9.997.870 | 21 |
| 2017-12-01 | A Clinical Phase IIB trial with 2OHOA in patients with newly-diagnosed malignant glioma. | CLINGLIO | participant | 6.155.125 | 12 |
| 2017-06-01 | Implications of Medical Low Dose Radiation Exposure | MEDIRAD | participant | 9.995.146 | 35 |
| 2011-01-01 | Predicting individual response and resistance to VEGFR/mTOR pathway therapeutic intervention using biomarkers discovered through tumour functional genomics | PREDICT | participant | 5.841.009 | 14 |